Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-24-032381
Filing Date
2024-08-14
Accepted
2024-08-14 17:07:55
Documents
1
Period of Report
2024-08-12

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1494
  Complete submission text file 0001493152-24-032381.txt   3229
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Issuer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO CA 94949
Business Address
Crombez Eric (Reporting) CIK: 0001653052 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-15771 | Film No.: 241209402